Abstract 12743: The Role of Combined Treatment With Ascorbic Acid and N-Acetylcysteine in Prevention of Contrast-Induced Nephropathy in High-Risk Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Marek Grygier,Magda Janus,Aleksander Araszkiewicz,Jadwiga Kowal,Tatiana Mularek-Kubzdela,Wojciech Seniuk,Anna Olasinska-Wisniewska,Małgorzata Popiel,Maciej Lesiak,Stefan Grajek

Abstract 12743: The Role of Combined Treatment With Ascorbic Acid and N-Acetylcysteine in Prevention of Contrast-Induced Nephropathy in High-Risk Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

2010

Marek Grygier
Magda Janus
Aleksander Araszkiewicz
Jadwiga Kowal
Tatiana Mularek-Kubzdela
Wojciech Seniuk
Anna Olasinska-Wisniewska
Małgorzata Popiel
Maciej Lesiak
Stefan Grajek

Background: Patients with acute myocardial infarction undergoing percutaneous coronary intervention (PCI) are at high-risk of contrast-induced nephropathy. Conflicting evidence suggests that admini...

Keywords:

Acetylcysteine
Contrast-induced nephropathy
Percutaneous coronary intervention
Diabetes mellitus
Cardiology
Internal medicine
Acute coronary syndrome
Medicine
Nephropathy
Myocardial infarction
Conventional PCI
ascorbic acid

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations